DiamiR Announces Corporate Presentation at Life Sciences Summit 2014
22 oct. 2014 08h02 HE
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - October 22, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Grant From The Michael J. Fox Foundation for Parkinson's Research to Advance Assessment of Brain-Enriched microRNA Biomarkers in Plasma
14 juil. 2014 11h00 HE
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - July 14, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
Neuronascent, Inc. Announces Issuance of US Patent Covering Second-Generation Neurorestorative Therapeutic Candidate
29 janv. 2014 07h00 HE
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - Jan 29, 2014) - Neuronascent, Inc. announced today the issuance of the United States patent covering a new compound family that includes Neuronascent's lead...
MIT Enterprise Forum of Cambridge Presents "Defeating Alzheimer's"
30 nov. 2011 08h30 HE
|
MIT Enterprise Forum
CAMBRIDGE, MA--(Marketwire - Nov 30, 2011) - On December 14, 2011 the MIT Enterprise Forum of Cambridge will present an Innovation Series event: "Defeating Alzheimer's." The disease devastates the...